08-27-2013 GeNO, LLC Announces Senior Management Appointment. Dr. Kurt Dasse Named Chief Executive Officer; Dr. David Fine to Serve as Executive Chairman and Chief Scientific Officer.
01-29-2013 New Pre-Clinical and Clinical Data on GeNO, LLC's Nitric Oxide Delivery Systems to be Presented at 2013 American College of Cardiology and American Thoracic Society Medical Meetings.
2013 News Archive 2012 News Archive 2011 News Archive
2012 News Archive 2011 News Archive
2011 News Archive
2010 News Archive